Drug Trial Radar · NCT06541704
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
975
Planned (sponsor's estimate)
Start
Oct 30, 2024
Primary completion
Jul 31, 2028
Study completion Apr 9, 2033
Sponsor
- Lead sponsor
- Regeneron PharmaceuticalsRegeneron (REGN)
- Sponsor type
- Industry
- First posted
- Aug 7, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is researching experimental (study) drugs called pozelimab and cemdisiran. The study is focused on participants who have Geographic Atrophy (GA) caused by Age-related Macular Degeneration (AMD). Geographic atrophy is a medical term that refers to later-stage cases of AMD which is an eye condition affecting central vision (what one sees straight ahead). The purpose of this study is to evaluate the progression rate of Geographic Atrophy in eyes of patients treated with cemdisiran alone or in combination with pozelimab compared to those treated with placebo. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug(s) * How much study drug(s) are in the blood at different times * Whether the body makes antibodies against the study drug(s) (which could make the study drug(s) less effective or could lead to side effects)
Conditions
- Age-related Macular Degeneration (AMD)
- Geographic Atrophy (GA)
Interventions
PozelimabDrug
Subcutaneous (SC) injection
CemdisiranDrug
SC injection
PlaceboDrug
SC injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Growth rate (slope) of total GA lesion area (mm^2 /year) from baseline, measured by Fundus Autofluorescence (FAF)Time frame: To week 52
Locations
233 sites in 11 countries. Site status is shown where the registry gives one.
Barnet Dulaney Perkins Eye Center-Ophthamalogy
Chandler, Arizona · Recruiting
Barnet Dulaney Perkins Eye Center
Phoenix, Arizona · Recruiting
Associated Retina Consultants
Phoenix, Arizona · Recruiting
Retinal Research Institute
Phoenix, Arizona · Recruiting
Retina Macula Institute of Arizona
Scottsdale, Arizona · Recruiting
Retina Associates of Tuscan
Tucson, Arizona · Recruiting
Retina Partners of Northwest Arkansas, PLLC
Springdale, Arkansas · Recruiting
Retina Vitreous Associates Medical Group
Beverly Hills, California · Recruiting
Retina Specialists of Beverly Hills- Department of Ophthalmology
Beverly Hills, California · Recruiting
The Retina Partners
Encino, California · Completed
Eye Medical Center of Fresno
Fresno, California · Recruiting
Retina Consultants of Orange County
Fullerton, California · Completed
Salehi Retina Institute dba Retina Associates of Southern California
Huntington Beach, California · Recruiting
University of California Irvine
Irvine, California · Recruiting
University of California San Diego, Jacobs Retina Center
La Jolla, California · Recruiting
South Coast Retina Center
Long Beach, California · Recruiting
American Institute of Research
Los Angeles, California · Completed
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California · Recruiting
Jules Stein Eye Institute in David Geffen School of Medicine at UCLA
Los Angeles, California · Recruiting
Retinal Consultants Medical Group Inc Modesto
Modesto, California · Recruiting
Northern California Retina Vitreous Associates Medical Group, Inc.
Mountain View, California · Recruiting
California Retina Consultants
Oxnard, California · Recruiting
Desert Retina Consultants
Palm Desert, California · Withdrawn
California Eye Specialists Medical Group Inc.
Pasadena, California · Recruiting
Retina Consultants San Diego
Poway, California · Recruiting
California Eye Specialists Medical Group, Inc.
Redlands, California · Recruiting
Kaiser Permanente Riverside Medical Center
Riverside, California · Recruiting
Optic Eye Care
Rowland Heights, California · Recruiting
UC Davis Health Eye Center
Sacramento, California · Recruiting
Vrmg Inc
Sacramento, California · Recruiting
Retinal Consultants Medical Group (RCMG) - Greenback Lane Retina Center
Sacramento, California · Recruiting
West Coast Retina Medical Group, Inc.
San Francisco, California · Recruiting
Orange County Retina Medical Group
Santa Ana, California · Recruiting
Macula Retina Vitreous Research Institute
Torrance, California · Recruiting
University of Colorado
Aurora, Colorado · Recruiting
Retina Consultants of Southern Colorado
Colorado Springs, Colorado · Recruiting
Retina Specialists of Colorado - Denver
Denver, Colorado · Recruiting
Southwest Retina Research Center
Durango, Colorado · Recruiting
Colorado Retina - Lakewood
Lakewood, Colorado · Recruiting
Eye care Center of Northern Colorado doing business as Advanced Vision Research Institute
Longmont, Colorado · Recruiting
Showing 40 of 233 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.